SIU Medicine
News

Finishing strong: 2020-25 Strategic Plan Progress Report

Published Date:

SIU School of Medicine instituted a five-year strategic plan in January 2020, just two months before the onset of the COVID-19 pandemic in Illinois. Despite the two-year imposition of this pandemic, remarkable progress has been made to advance this plan. Across the organization, we have used this plan frequently as decisions are made to further our mission, vision and partnerships.
 
A new progress report (linked below) has been published to outline the accomplishments that reflect the resilience, innovation and unwavering commitment of our entire SIU Medicine community.  We are proud of what we’ve achieved and are determined to finish strong.

To honor that commitment and to sustain our momentum, SIU Medicine will extend the current strategic plan through December 2026.  This will allow us to fully realize the remaining goals, deepen the impact, and carry forward the collaborative energy that has defined the last five years.

I am proud of the progress that you have made on these goals.  Your work in all areas has been exemplary.  May it deepen your dedication to our shared mission and inspire all of us to finish this plan with purpose, unity and excellence.

-  Jerry Kruse, MD, MSPH, Dean and Provost

More from SIU News

healthy foods

SIU Family Medicine offers Diabetes Wellness Workshop on Feb. 11

SIU Center for Family Medicine has been selected as one of only 10 organizations nationwide to participate in the American Diabetes Association’s Obesity Master Trainer program, a designation that
Seed grants, light bulb with seedlings

Small dollars, big discoveries

Fall 2025 SIU Seed Grants have been awarded. These seed grants reflect SIU School of Medicine’s broader commitment to research that matters locally and resonates globally.
Dr. Noor Khalid, abstract achievement award

SIU Medicine fellow’s research finds older cancer patients live longer with chemotherapy

Inspired by patient conversations, Dr. Noor Khalid analyzed 20 years of data to better understand survival outcomes for seniors with blood cancer.